Category: Speeches

  • Christopher Chope – 2016 Parliamentary Question to the Department for Energy and Climate Change

    Christopher Chope – 2016 Parliamentary Question to the Department for Energy and Climate Change

    The below Parliamentary question was asked by Christopher Chope on 2016-01-13.

    To ask the Secretary of State for Energy and Climate Change, pursuant to the Answer of 12 January 2016 to Question 21401, what her Department’s policy is on energy issues affecting park homes.

    Andrea Leadsom

    Park home residents are able to benefit from DECC policies aimed at improving the energy efficiency of homes and helping with energy bills. This includes the Energy Company Obligation, Green Deal Communities, the Renewable Heat Incentive, the Warm Home Discount and the Central Heating Fund.

  • Andrew Rosindell – 2016 Parliamentary Question to the Department for Transport

    Andrew Rosindell – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Andrew Rosindell on 2016-02-08.

    To ask the Secretary of State for Transport, what steps he is taking to encourage competition between rail services providers in the UK.

    Claire Perry

    Since the launch of the franchising programme in March 2013, the Department has introduced a series of measures aimed at increasing the number of companies in the market.

    Working with UKTI and other partners in Government, we have been actively seeking potential new entrants. We have engaged closely with a number of companies that are looking to join the market and have provided advice on the conditions and qualities of our market so they can begin the process of entry.

  • Douglas Carswell – 2016 Parliamentary Question to the Department of Health

    Douglas Carswell – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Douglas Carswell on 2016-02-26.

    To ask the Secretary of State for Health, with reference to the Prime Minister’s Oral Statement of 22 February 2016, Official Report, column 35, on the European Council, whether his Department is undertaking planning in the eventuality of a majority leave vote in the EU referendum.

    Jane Ellison

    At the February European Council, the Government negotiated a new settlement, giving the United Kingdom a special status in a reformed European Union. The Government’s position, as set out by the Prime Minister to the House on 22 February, is that the UK will be stronger, safer and better off remaining in a reformed EU.

  • Wes Streeting – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Wes Streeting – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Wes Streeting on 2016-03-24.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what progress has been made on implementation of the UN Human Rights Council Resolution 30/1 on Sri Lanka.

    Mr Hugo Swire

    Sri Lanka has made encouraging progress towards fulfilling its commitments to UNHRC Resolution 30/1 but we recognise there remains much to be done. We look forward to the UN High Commissioner for Human Rights’ assessment of progress at the next Human Rights Council in June.

  • Diane Abbott – 2016 Parliamentary Question to the Department for International Development

    Diane Abbott – 2016 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by Diane Abbott on 2016-05-04.

    To ask the Secretary of State for International Development, with reference to the recommendations of the report of the Public Accounts Committee, Department for International Development: responding to crises, published on 20 April 2016, what steps she is taking to ensure that her Department improves its system of accounting for ODA spend on humanitarian emergencies.

    Justine Greening

    The Government will respond to the Committee’s recommendations in the usual way in a Treasury Minute which will be laid before Parliament.

  • Gloria De Piero – 2016 Parliamentary Question to the Department of Health

    Gloria De Piero – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Gloria De Piero on 2016-06-20.

    To ask the Secretary of State for Health, what the one-year survival rates are for women diagnosed with cervical cancer following (a) a routine smear test and (b) diagnosis by other means.

    Jane Ellison

    Cervical screening is not a test for cancer. Cervical screening detects abnormalities within the cervix that could, if undetected and untreated, develop into cervical cancer. It is unusual to detect an invasive cervical cancer on a screening test and this would need to be confirmed by a diagnostic test.

    For those cervical cancers which are detected through screening, the one-year relative survival is 99%. This compares to 86% for all cervical cancers; 83% for those diagnosed after a Two Week Wait referral; and 45% for those diagnosed as an emergency.

  • Lord Patten – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Lord Patten – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Lord Patten on 2016-09-05.

    To ask Her Majesty’s Government, further to the Written Answer by Baroness Anelay of St Johns on 19 July (HL1204), whether they will now list the competent courts that can recognise genocide.

    Baroness Anelay of St Johns

    We continue to believe that recognition of genocide should be a matter for competent courts, decided by judges after consideration of all the evidence available in the context of a credible judicial process. A recent example was in March 2016, when the Trial Chamber of the International Criminal Tribunal for the former Yugoslavia (ICTY) convicted Radovan Karadžić of one count of genocide (along with other crimes) and sentenced him to forty years imprisonment. The UK is fully committed to the principle that there must be no impunity for the most serious international crimes.

  • Alison Thewliss – 2016 Parliamentary Question to the Department of Health

    Alison Thewliss – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Alison Thewliss on 2016-10-20.

    To ask the Secretary of State for Health, whether his Department plans to (a) reprint and (b) revise the Start4Life leaflets covering breastfeeding, bottle feeding and early child nutrition.

    Nicola Blackwood

    Public Health England will continue to reprint Start4Life leaflets on breastfeeding (in a simpler format) and bottle feeding, and will be revising the early child nutrition leaflet to incorporate new guidance from the Scientific Advisory Committee on Nutrition, when available.

  • Alex Cunningham – 2015 Parliamentary Question to the Department for Transport

    Alex Cunningham – 2015 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Alex Cunningham on 2015-11-04.

    To ask the Secretary of State for Transport, whether his Department has assessed the necessary financial support required by local authorities to deliver a charging network for electric vehicles of the scale required to have an effect on local air quality.

    Andrew Jones

    The Government wants almost every car and van to be a zero emission vehicle by 2050 and is investing £500m between 2015 and 2020 to help deliver this. The long-term transition to ultra low emission vehicles can help improve local air quality, and will also lower UK greenhouse gas emissions and provide high value jobs and growth, but our modelling suggests that even very rapid uptake can have only a marginal impact on today’s air quality problems because of the time taken to turn over the vehicle fleet.

    We are aware that a number of local authorities have been assessing electric car charging point requirements in air quality management areas.

    The Government is considering future grid and chargepoint requirements as part of its planning for this transition. The UK already has the largest network of rapid chargepoints across Europe and over 6000 publically accessible chargepoints have been part-funded by the Government. We will continue to collaborate with industry to ensure that the UK’s infrastructure network meets the needs of electric vehicle drivers.

  • Graham Brady – 2015 Parliamentary Question to the Department of Health

    Graham Brady – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Graham Brady on 2015-12-02.

    To ask the Secretary of State for Health, what information his Department holds on the efficacy of anakinra for patients diagnosed with idiopathic recurrent pericarditis; and what the (a) target, (b) average and (c) longest time taken to approve that drug for use was in the last 12 months for which data is available.

    George Freeman

    The Medicines and Healthcare products Regulatory Agency (MHRA) does not hold information concerning the efficacy of anakinra for patients diagnosed with idiopathic recurrent pericarditis.

    Kineret, containing the active substance anakinra, was approved by the European Medicines Agency (EMA) in 2002 for the treatment of rheumatoid arthritis in adults. The licence was extended to include treatment of Cryopyrin-Associated Periodic Syndromes. Anakinra is not licensed to treat idiopathic recurrent pericarditis.

    The EMA is required to issue an opinion on applications for new indications within 90 days of receipt of a valid application. This period will be extended if it needs to request supplementary information from the applicant. The applicant will be requested to provide supplementary information within one month, although this may be extended to two months. The assessment of any supplementary information by EMA should be completed within 60 days. The European Commission is required to amend the marketing authorisation within two months of the EMA opinion.

    The MHRA does not hold information on average and longest time for approval of variations by EMA.